EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis

Halima Dawood iD, Nonhlanhla Yende-Zuma, Upasna Singh iD, Mikaila C Moodley, Jenine Ramruthan, Kogieleum Naidoo

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0297224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Halima Dawood und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases, Coinfection, Tuberculosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, NCHHSTP CDC HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Hypertension is a leading risk factor for cardiovascular disease among people living with human immunodeficiency virus (PLWH). This study determined incidence and prevalence of hypertension among PLWH receiving antiretroviral therapy (ART).

Method

We prospectively followed-up 642 HIV and tuberculosis (TB) co-infected study participants from 2005–2013. We defined hypertension as two consecutive elevated systolic and/or diastolic blood pressure measurements above 139/89 mmHg or current use of antihypertensive therapy.

Results

Of 507 participants analyzed, 53% were women. Median [interquartile range (IQR)] age, body mass index (BMI), and CD4 count was 34 (28.0–40.0) years, 22.7 (20.5–25.4) kg/m 2 , and 145 (69.0–252.0) cells/mm 3 , respectively. Incidence [95% confidence interval (CI)] of both systolic and diastolic hypertension overall, in men, and in women over 40 years was 1.9 (1.4–2.6), 5.9 (3.6–9.6), and 5.0 (2.7–9.3) per 100 person-years (PY), respectively. Risk of developing hypertension was higher in men [(adjusted hazard ratio (aHR) 12.04, 95% CI: 4.35–33.32)] and women over 40 years (aHR 8.19, 95% CI 2.96–22.64), and in men below 40 years (aHR 2.79, 95% CI 0.95–8.23).

Conclusion

Higher incidence rates of hypertension among older men and women accessing ART highlight opportunities to expand current integrated HIV-TB care models, to include cardiovascular disease risk screening and care to prevent premature death.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCardiovascular DiseasesCoinfectionTuberculosisHypertensionMaleHumansFemaleAgedHIVIncidenceProspective StudiesPrevalenceCohort StudiesRisk Factors

Autor:innen und Institutionen

  • Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
  • Department of Internal Medicine, Infectious Diseases, Greys Hospital, Pietermaritzburg, South Africa.
  • MRC-CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.

ORCID-Profile: Halima Dawood, Upasna Singh

Förderung

  • Medical Research Council
  • NCHHSTP CDC HHS
  • Howard Hughes Medical Institute
  • South African Medical Research Council

Zitieren

APA

Dawood, H., Yende-Zuma, N., Singh, U., Moodley, M. C., Ramruthan, J., & Naidoo, K. (2024). Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0297224

Vancouver

Dawood H, Yende-Zuma N, Singh U, Moodley MC, Ramruthan J, Naidoo K. Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0297224

BibTeX
@article{Dawood2024,
  author = {Dawood, Halima and Yende-Zuma, Nonhlanhla and Singh, Upasna and Moodley, Mikaila C and Ramruthan, Jenine and Naidoo, Kogieleum},
  title = {Incidence and prevalence of hypertension among HIV-TB co-infected participants accessing treatment: A five-year prospective cohort analysis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0297224}
}
Kostenlos starten →